We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
-$216M
Cap. Flow
-$62.5M
Cap. Flow %
-1.18%
Top 10 Hldgs %
23.94%
Holding
294
New
29
Increased
89
Reduced
98
Closed
32

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$46.6M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
BCR
CR Bard Inc.
BCR
+$31.1M
4
CVS icon
CVS Health
CVS
+$27.8M
5
DHR icon
Danaher
DHR
+$26.6M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$36.5M
2
PNC icon
PNC Financial Services
PNC
+$34.3M
3
CELG
Celgene Corp
CELG
+$32.4M
4
AGN
Allergan plc
AGN
+$28M
5
CNC icon
Centene
CNC
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 23.21%
3 Financials 21.91%
4 Communication Services 9.94%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHN
176
DELISTED
Athenahealth, Inc.
ATHN
$3.78M 0.07%
27,225
+18,225
+203% +$2.5M
WDAY icon
177
Workday
WDAY
$36.4B
$3.74M 0.07%
+48,655
New +$3.22M
AMGN icon
178
Amgen
AMGN
$203B
$3.6M 0.07%
24,029
-921
-4% -$137K
ALXN
179
DELISTED
Alexion Pharmaceuticals
ALXN
$3.52M 0.07%
25,319
-162,334
-87% -$23.8M
MAIN icon
180
Main Street Capital
MAIN
$5B
$3.52M 0.07%
112,500
-84,500
-43% -$2.45M
REGN icon
181
Regeneron Pharmaceuticals
REGN
$69.9B
$3.26M 0.06%
9,047
-55,031
-86% -$22.7M
PPLI
182
People Inc
PPLI
$3.15B
$3.07M 0.06%
364,921
-852,556
-70% -$7.34M
SIVB
183
DELISTED
SVB Financial Group
SIVB
$3.05M 0.06%
29,901
+25,825
+634% +$2.5M
SCOR icon
184
Comscore
SCOR
$107M
$3.03M 0.06%
5,050
-7,511
-60% -$5.43M
BFH icon
185
Bread Financial
BFH
$4.29B
$3.03M 0.06%
17,285
-8,661
-33% -$1.51M
RNG icon
186
RingCentral
RNG
$4.5B
$2.87M 0.05%
182,394
-94,232
-34% -$1.76M
MPT
187
Medical Properties Trust
MPT
$2.86B
$2.59M 0.05%
200,000
– –
ZD icon
188
Ziff Davis
ZD
$1.93B
$2.44M 0.05%
45,540
– –
HAR
189
DELISTED
Harman International Industries
HAR
$2.42M 0.05%
27,196
-96,175
-78% -$7.64M
BDX icon
190
Becton Dickinson
BDX
$43.8B
$2.39M 0.05%
16,164
+789
+5% +$112K
CERN
191
DELISTED
Cerner Corp
CERN
$2.21M 0.04%
+41,742
New +$2.27M
AEM icon
192
Agnico Eagle Mines
AEM
$73B
$2.21M 0.04%
+60,000
New +$1.97M
APIC
193
DELISTED
Apigee Corporation Common Stock
APIC
$2M 0.04%
240,893
+140,264
+139% +$1.04M
TU icon
194
Telus
TU
$16.2B
$1.87M 0.04%
99,000
– –
NMFC icon
195
New Mountain Finance
NMFC
$649M
$1.86M 0.04%
147,500
+15,000
+11% +$182K
SUPN icon
196
Supernus Pharmaceuticals
SUPN
$2.73B
$1.86M 0.04%
122,086
+16,065
+15% +$210K
HR
197
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.85M 0.03%
60,000
– –
DHC
198
Diversified Healthcare Trust
DHC
$2.28B
$1.79M 0.03%
100,000
– –
OHI icon
199
Omega Healthcare
OHI
$15.3B
$1.76M 0.03%
50,000
– –
NHI icon
200
National Health Investors
NHI
$3.84B
$1.66M 0.03%
25,000
– –
6 7
8
9 10

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Polar Capital held 294 positions worth $5.32B, down 3.9% from $5.53B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2016 filing shows 29 new, 89 increased, 98 reduced and 32 closed positions. Its largest new stake was Union Pacific: 603,004 shares worth $48M. The largest sale was Bristol-Myers Squibb, an estimated $36.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2016 buy was Union Pacific: 603,004 shares worth $48M.
  • Polar Capital added most to Gilead Sciences in Q1 2016, an estimated $37M increase.
  • Polar Capital's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $36.5M.
  • Polar Capital fully exited Centene in Q1 2016, selling an estimated $27.3M.
  • Polar Capital's ten largest holdings make up 24% of its $5.32B portfolio in Q1 2016.
  • Polar Capital opened 29 new positions and closed 32 in Q1 2016.
  • Polar Capital's portfolio value fell 3.9% quarter-over-quarter to $5.32B.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.